Sitemap

• About Eurand
  • Corporate Fact Sheet
  • Strategy
  • Management
  • Board of Directors
  • Locations
    • Amsterdam
    • Dayton
    • Milan
    • Paris
    • Philadelphia
    • Trieste
• Products
  • Development Pipeline
    • EUR-1008
    • EUR-1048
    • EUR-1000
    • EUR-1025
    • EUR-1073
  • In-Licensing Opportunities
  • Out-Licensing Opportunities
  • Manufacturing
    • Facilities
• Technologies/Solutions
  • Development Pipeline
    • EUR-1000
    • EUR-1008
    • EUR-1025
    • EUR-1047
    • EUR-1048
  • Bioavailability Enhancement
    • Biorise®
  • Controlling Drug Release
    • Sustained Release
    • Modified Release
    • Pulsatile Release
    • Chrono Release
    • Targeted Delivery
    • Diffucaps®
    • Diffutab®
    • Orbexa®
    • Eurand Minitabs®
  • Dosage Form Technology
    • AdvaTab®
    • Liquitard®
    • Microcaps®
  • Drug Conjugation
  • Articles/Papers
    • White papers
    • Articles
    • Posters
  • Intellectual Property
• News/Events
  • News
  • Events
  • Articles/Papers/Posters
    • White Papers
    • Articles
    • Posters
• Careers
  • Career Opportunities
• Investor Information

• About Eurand
• Products
• Technologies/Solutions
• News/Events
• Careers
• Investor Information

© 2002-2007 Eurand, All rights reserved

• Sitemap
• Terms and conditions
• Privacy policy

• Home
• Contact Us